Functional cure with single agent olutasidenib in relapsed IDH1/NPM1 co-mutated AML

Overview of attention for article published in npj Precision Oncology, July 2025

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog

twitter: 14 X users

Readers on

mendeley: 2 Mendeley

So far, Altmetric has seen 15 X posts from 14 X users, with an upper bound of 36,027 followers.

RT @TaylorJ_MD: Our new paper is out @Nature_NPJ Precision Oncology! https://t.co/Q0BuRS6nMI With @JustinWattsMD and colleagues @Sylvester…

Hi friends, it's #AcuteMyeloidLeukemia Thursday. Here are Top Posts of the Week! 🎉🎉🎉 1/ @TaylorJ_MD on the first patient cured by single-agent IDH1 inhibition with olutasidenib: https://t.co/lroNcznsqr

Fascinating results and data! Great work @TaylorJ_MD and team! https://t.co/uP7ZjahAu8

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 11 additional X posts.